Intern, Internal Controls: June- August (Hybrid)
Insulet Corporation
Summary
Insulet Corporation is seeking a motivated and detail-oriented Internal Controls intern to join our Internal Controls Department. This intern will assist in ensuring that Insulet adheres to SOX requirements and maintains robust internal controls. The ideal candidate will have a strong academic background, relevant internship or co-op experience, and an interest in accounting, internal controls and risk management.
Job description
Responsibilities
- Assist in the documentation and testing of internal controls over financial reporting
- Support the preparation and review of SOX compliance documentation
- Participate in the evaluation of control deficiencies and the development of remediation plans
- Collaborate with various departments to ensure compliance with SOX requirements
- Assist in the preparation of reports for management and external auditors
- Conduct research on SOX-related topics
- Perform other duties as required
Education and Experience
Minimum Requirements:
- Currently pursuing a Bachelor’s degree in Business Administration with a concentration in Accounting / Finance or Systems/Technology
- Minimum GPA of 3.0
Preferred Skills and Competencies
- Strong analytical and problem-solving skills
- Excellent written and verbal communication skills
- Proficiency in Microsoft Office Suite (Excel, Word, PowerPoint)
- Ability to work independently and as part of a team
- High level of integrity and professionalism
Requirements
- Currently pursuing a Bachelor’s degree in Business Administration with a concentration in Accounting / Finance or Systems/Technology
- Minimum GPA of 3.0
- Authorization to work in the U.S. without current or future sponsorship needs
Benefits
- Medical insurance
- Holiday pay
- Sick time off
- Employee wellness programs
Company overview
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, founded in 2000 with a mission to improve the lives of people with diabetes. The company specializes in developing, manufacturing, and marketing the revolutionary Omnipod Insulin Management System, which provides a unique alternative to traditional insulin delivery methods. The Omnipod system features a tubeless, disposable wearable Pod that delivers up to three days of continuous insulin without the need for needles or tubing. Insulet's flagship product, the Omnipod 5 Automated Insulin Delivery System, integrates with continuous glucose monitors to manage blood sugar levels automatically, eliminating multiple daily injections and fingersticks. With operations spanning 25 countries across North America, Europe, the Middle East, and Asia Pacific, Insulet has established itself as a global leader in diabetes management technology. The company employs between 1,001-5,000 professionals dedicated to advancing diabetes care through innovative medical device solutions.